Short Interest in Sanofi (OTCMKTS:SNYNF) Decreases By 20.7%

Sanofi (OTCMKTS:SNYNFGet Rating) was the recipient of a significant decline in short interest during the month of April. As of April 30th, there was short interest totalling 1,243,300 shares, a decline of 20.7% from the April 15th total of 1,567,400 shares. Based on an average trading volume of 4,300 shares, the short-interest ratio is currently 289.1 days.

Separately, Stifel Nicolaus began coverage on shares of Sanofi in a research report on Monday, February 28th. They set a “buy” rating and a $120.00 price objective for the company.

Shares of OTCMKTS SNYNF opened at $101.58 on Monday. Sanofi has a 52-week low of $92.01 and a 52-week high of $115.37. The firm has a 50 day moving average price of $105.10 and a two-hundred day moving average price of $102.74.

Sanofi Company Profile (Get Rating)

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products.

See Also

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.